NEW YORK (GenomeWeb News) – The Blue Genomics Consortium Chile is providing $17 million in funding to perform genomics-based research into why some Atlantic salmon and trout seem resistant to Caligus and Salmon Rickettsial Syndrome (SRS).

Chilean government organization Corporation for Production Development (CORFO) last year approved $7.9 million to the project, which includes four partners, AquaGen Norway, Chile AquaGen, German vaccine production firm Vaxxinova, and Norwegian company BioBank.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.